WHO ICTRP trial
Study to compare the efficacy and safety of Deflazacort tablets versus…
CTRI/2020/08/027069 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/08/027069 |
|---|---|
| Public title | Study to compare the efficacy and safety of Deflazacort tablets versus Prednisolone Tablets versus Methylprednisolone Tablets in patients with Chronic Obstructive Pulmonary Disease (COPD) |
| Scientific title | A Prospective, Randomized, Open-label, Investigator-initiated Study to Evaluate the Short-term and Long-term Efficacy and Safety of Deflazacort Tablets, Prednisolone Tablets and Methylprednisolone Tablets in Patients with COPD |
| Primary sponsor | Lokmanya Medical Research Center |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified |
| Interventions | Intervention1: Deflazacort Tablets (Macleods Pharmaceuticals Ltd.) : Oral Deflazacort Tablets 0.5-1.0 mg/kg/day Investigators are allowed to adjust study treatment regimen (dose per day, frequency per day, total duration of treatment) as… |
| Registration date | Oct 8, 2020 |
| Target size | 60 |
| Secondary IDs | CT-009-DEFL-2019 Ver 1.0 27 Nov 2019 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: